• 

  Glenmark Life Sciences IPO Listing today, GMP indicated moderate listing gain

  August 06, 2021 8:03 IST

  Glenmark Life Sciences IPO Listing Date, Glenmark Life Sciences Share Price: Glenmark Life Sciences IPO GMP is currently at Rs 85.

• 

  Glenmark Life Sciences IPO share allotment status finalised, available on KFintech's website

  August 04, 2021 8:27 IST

  Glenmark Life Sciences IPO Allotment status, Glenmark IPO GMP today: Glenmark Life Sciences IPO allotment status has been finalised. Glenmark IPO allotment status is available on KFintech's website. Glenmark Life Sciences shares will be listed on the BSE and NSE on August 6. 

• 

  Glenmark IPO Allotment Date, Status: Glenmark Life Sciences IPO GMP weak; Check listing date

  August 03, 2021 18:24 IST

  Glenmark Life Sciences IPO Allotment, Glenmark Life Sciences IPO GMP Latest: Glenmark Life Sciences IPO allotment status will be available on the website of KFintech.

• 

  Glenmark Life Sciences IPO GMP falling, Why?

  August 02, 2021 10:40 IST

  Glenmark IPO Allotment Date, Glenmark Life Sciences IPO GMP: Glenmark Life Sciences is a subsidiary of Glenmark Pharmaceuticals. Glenmark Life Sciences IPO listing date is August 6.

• 

  Glenmark Life Sciences IPO to open on July 27 | Check price band, lot size, other details

  July 21, 2021 14:54 IST

  The public issue will have a fresh issue of equity shares worth up to Rs 1,060 crore and sale of up to 63 lakh equity shares by Glenmark Pharma.

• 

  Glenmark Pharma launches anti-epileptic drug in US

  India | June 01, 2021 12:23 IST

  Banzel tablets are used in combination with other medications to treat children with Lennox-Gastaut syndrome, a severe form of childhood epilepsy that also causes developmental and behavior problems

• 

  Glenmark Pharma gets USFDA nod for seizure treatment drug

  India | February 03, 2021 10:30 IST

  Shares of Glenmark Pharmaceuticals were trading 2.41 per cent higher at Rs 499.10 apiece on the BSE.

• 

  Glenmark Pharma gets tentative nod from USFDA for anticoagulant drug

  World | December 21, 2020 11:56 IST

  Drug major Glenmark Pharma on Monday said it has received tentative approval from the US health regulator for anticoagulant Dabigatran Etexilate capsules.

• 

  Glenmark Pharma gets USFDA nod for Tacrolimus capsules

  India | November 11, 2020 11:22 IST

  Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Tacrolimus capsules, used as immuno-suppressant.

• 

  Glenmark Pharma gets USFDA nod for generic drug

  India | October 19, 2020 10:54 IST

  Glenmark Pharmaceuticals on Monday said it has received approval from the US health regulator to market Sirolimus tablets, an immunosuppressant, in the American market. 

• 

  Glenmark Pharma launches pulmonary fibrosis treatment drug in India

  India | October 14, 2020 11:26 IST

  Glenmark Pharma on Wednesday announced the launch of its generic version of Nintedanib (NINDANIB), used for the treatment of pulmonary fibrosis, in India.

Advertisement
• 

  Glenmark Pharma shares soar 27% after COVID-19 drug FabiFlu launch

  Business | June 22, 2020 19:00 IST

  Shares of Glenmark Pharmaceuticals on Monday rallied 27 per cent after the company said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19.

• 

  Glenmark Pharma receives USFDA approval for Xylocaine skin ointment

  Lifestyle | September 12, 2016 13:32 IST

  Glenmark Pharmaceuticals on Monday received final approval from the US health regulator USFDA for its generic version of AstraZeneca's Xylocaine ointment. The approval given by the US Food & Drug Administration (USFDA) to Glenmark Pharmaceuticals

• 

  Glenmark Pharma hits 52-week high after Forest Lab deal

  December 24, 2012 12:19 IST

  New Delhi, Dec 24: Glenmark Pharmaceuticals rose by 4 per cent to hit its 52-week high of Rs 519.70 following the company's collaboration with Forest Laboratories for worldwide collaboration on Novel Agents to treat chronic